Clinical Trials Browser

Phase 2 × HER2-positive Breast Cancer × Cyclophosphamide × Clear all

NCT07635342 2026-06-09

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

Phase 2 Recruiting

HER2-positive Breast Cancer